Article

The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
Journal of Virology (Impact Factor: 4.65). 10/2010; 84(19):9995-10003. DOI: 10.1128/JVI.00505-10
Source: PubMed

ABSTRACT The majority of HIV-1 infections around the world result from non-B clade HIV-1 strains. The CRF01_AE (AE) strain is seen principally in Southeast Asia. AE protease differs by approximately 10% in amino acid sequence from clade B protease and carries several naturally occurring polymorphisms that are associated with drug resistance in clade B. AE protease has been observed to develop resistance through a nonactive-site N88S mutation in response to nelfinavir (NFV) therapy, whereas clade B protease develops both the active-site mutation D30N and the nonactive-site mutation N88D. Structural and biochemical studies were carried out with wild-type and NFV-resistant clade B and AE protease variants. The relationship between clade-specific sequence variations and pathways to inhibitor resistance was also assessed. AE protease has a lower catalytic turnover rate than clade B protease, and it also has weaker affinity for both NFV and darunavir (DRV). This weaker affinity may lead to the nonactive-site N88S variant in AE, which exhibits significantly decreased affinity for both NFV and DRV. The D30N/N88D mutations in clade B resulted in a significant loss of affinity for NFV and, to a lesser extent, for DRV. A comparison of crystal structures of AE protease shows significant structural rearrangement in the flap hinge region compared with those of clade B protease and suggests insights into the alternative pathways to NFV resistance. In combination, our studies show that sequence polymorphisms within clades can alter protease activity and inhibitor binding and are capable of altering the pathway to inhibitor resistance.

0 Followers
 · 
151 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The human immunodeficiency virus type 1 protease (HIV-1 PR) is an attractive target in AIDS therapies that utilize protease inhibitors (PIs) because this enzyme is required for viral maturation. However, the rapid emergence of drug-pressure selected mutations in the HIV genome after exposure to PIs often results in drug resistance. The understanding of the molecular mechanism by which the accumulation of mutations imparts resistance to PIs is important for future drug design. We used double electron-electron resonance (DEER) spectroscopy to illuminate how amino acid substitutions in the apo protease and in the presence of inhibitors result in perturbations of the equilibrium fractional occupancies of HIV-1 PR conformational populations. We found that drug resistance emerges from combinations of mutations that stabilize open-like conformations while destabilizing the closed state and retaining the semi-open population seen in native protease. Changes in protease flap conformations were also monitored in the presence of inhibitors in the multi-drug resistant HIV-1 PR variant MDR769. Specifically, variations in inhibitor IC50 values compared to the native enzyme are related to the relative change in the inhibitor-induced shift to the closed state, |ΔC|. A linear correlation was found between |ΔC| and the fold-change in IC50 when inhibitor-binding is not too weak. In 1H-15N heteronuclear single quantum coherence (HSQC) titration experiments for MDR769, asymmetric inhibitors that have longer residence time in the protease binding pocket showed peak splitting of several HSQC resonances because of slow exchange in the NMR timescale. Peak splitting coincided with strong induction of flap closure based on DEER results. On the other hand, several resonances were missing in the HSQC spectra when an inhibitor undergoes intermediate exchange in the NMR timescale with the binding cleft. Peak disappearances due to broadened line widths of several HSQC peaks were consistent with weak inhibitor-induced flap closure. Finally, we compared the residue-specific backbone flexibility of MDR769 with subtype B protease by measuring 15N spin relaxation parameters, namely T1, T2 and NOE. Results suggest that the flap elbow and T80 loop of MDR769 are more rigid relative to subtype B.
    11/2012, Degree: PhD, Supervisor: Gail E. Fanucci
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: On October 28th 1943 Winston Churchill said "we shape our buildings, and afterward our buildings shape us" (Humes, 1994). Churchill was pondering how and when to rebuild the British House of Commons, which had been destroyed by enemy bombs on May 10th 1941. The old House had been small and insufficient to hold all its members, but was restored to its original form in 1950 in order to recapture the "convenience and dignity" that the building had shaped into its parliamentary members. The circular loop whereby buildings or dwellings are shaped and go on to shape those that reside in them is also true of pathogens and their hosts. As obligate parasites, pathogens need to alter their cellular host environments to ensure survival. Typically pathogens modify cellular transcription profiles and in doing so, the pathogen in turn is affected, thereby closing the loop. As key orchestrators of gene expression, non-coding RNAs provide a vast and extremely precise set of tools for pathogens to target in order to shape the cellular environment. This review will focus on host non-coding RNAs that are manipulated by the infamous intracellular pathogen, the human immunodeficiency virus (HIV). We will briefly describe both short and long host non-coding RNAs and discuss how HIV gains control of these factors to ensure widespread dissemination throughout the host as well as the establishment of lifelong, chronic infection.
    Frontiers in Genetics 01/2015; 6:108. DOI:10.3389/fgene.2015.00108
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since its identification, HIV continues to have a detrimental impact on the lives of millions of people throughout the world. The protease of HIV is a major target in antiviral treatment. The South African HIV-1 subtype C (C-SA) protease displays weaker binding affinity for some clinically-approved protease inhibitors in comparison to the HIV-1 subtype B protease. The heavy HIV burden in sub-Saharan Africa, where subtype C HIV-1 predominates, makes this disparity a topic of great interest. In light of this, the enzyme activity and affinity of protease inhibitors for the subtype B and C-SA proteases were determined. The relative vitality, indicating the selective advantage of polymorphisms, of the C-SA protease relative to the subtype B protease in the presence of ritonavir and darunavir was 4-fold and 10-fold greater, respectively. Dynamic differences that contribute to the reduced drug susceptibility of the C-SA protease were investigated by performing hydrogen/deuterium exchange-mass spectrometry (HDX-MS) on the unbound subtype B and C-SA proteases. The reduced propensity to form the E35-R57 salt bridge and alterations in the hydrophobic core of the C-SA protease is proposed to affect the anchoring of the flexible flaps resulting in an increased proportion of the fully-open flap conformation. HDX-MS data showed that the N-terminus of both proteases appears to be less stable than the C-terminus of the proteases, thus rationalising the increased efficacy of dimerisation inhibitors targeted toward the C-terminus of HIV proteases. This is the first known report on HIV protease dynamics using HDX-MS.This article is protected by copyright. All rights reserved.
    FEBS Journal 10/2014; 281(24). DOI:10.1111/febs.13084 · 3.99 Impact Factor

Full-text (2 Sources)

Download
50 Downloads
Available from
May 23, 2014